Arizona State Retirement System Myovant Sciences Ltd. Transaction History

Arizona State Retirement System

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$24.03 - $27.02 $12,543 - $14,104	522 Added 4.48%	12,180 $328,000
Q3 2022 Nov 07, 2022	BUY	$11.6 - $20.44 $2,389 - $4,210	206 Added 1.8%	11,658 $209,000
Q2 2022 Jul 28, 2022	BUY	$7.78 - $14.69 $10,604 - $20,022	1,363 Added 13.51%	11,452 $142,000
Q1 2022 May 04, 2022	BUY	$11.38 - $16.4 $114,812 - $165,459	10,089 New	10,089 $134,000
Q4 2021 Feb 04, 2022	SELL	$14.31 - $23.87 $142,627 - $237,912	-9,967 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$18.94 - $26.99 $1,780 - $2,537	94 Added 0.95%	9,967 $224,000
Q2 2021 Aug 02, 2021	SELL	$17.07 - $24.56 $11,539 - $16,602	-676 Reduced 6.41%	9,873 $225,000
Q1 2021 May 06, 2021	BUY	$20.46 - $25.18 $2,291 - $2,820	112 Added 1.07%	10,549 $217,000
Q4 2020 Jan 28, 2021	SELL	$13.8 - $27.62 $5,644 - $11,296	-409 Reduced 3.77%	10,437 $288,000
Q3 2020 Nov 05, 2020	BUY	$14.05 - $22.6 $152,386 - $245,119	10,846 New	10,846 $152,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.